- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT04345328
Impact of Bariatric Surgery on the Gut Environment (IMPORTUNE)
Impact of the Bacterial Colonial Metabolism on Fecal Water Toxicity as Biomarkers of Future Colorectal Cancer Risk After Bariatric Surgery
Studieoversikt
Status
Forhold
Detaljert beskrivelse
To quantify protein assimilation after bariatric surgery, the investigators will perform in bariatric surgery patients (Roux-en- Y gastric bypass and Sleeve Gastrectomy) and in a control group a cross-sectional study with a single test day. On the test day, the study participants will consume a test meal that contains intrinsically labelled egg proteins and will take a capsule with 14C-glycocholic acid and a capsule with 3H-labelled polyethylene glycol. Participants will record a food diary 72h before and after the test day and during the test collect breath samples for 6h. Urine and stool will be collected respectively up to 24h and 72h after consumption of the test meal.
For the 1-year follow up study, the 3 patient groups (Roux-en-Y gastric bypass, Sleeve gastrectomy and control group with traditional weight loss therapy) will have 5 visits, a baseline visit and 4 visits after surgery or after starting traditional therapy. The time points after baseline include 2 weeks, 3 months, 6 months and 12 months. Each visit, a blood and stool sample will be collected, a 7-day food and stool diary will be registered and also weight loss will be recorded.
Studietype
Registrering (Faktiske)
Kontakter og plasseringer
Studiesteder
-
-
Vlaams-Brabant
-
Leuven, Vlaams-Brabant, Belgia, 3000
- University Hospital Leuven
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Prøvetakingsmetode
Studiepopulasjon
- Surgery patient group was recruited at the University Hospital Leuven.
- Obese control group was recruited at the Obesity Clinic of the University Hospital Leuven.
- Normal and overweight control group was recruited among the employees and family members from employees of the University Hospital Leuven.
Beskrivelse
Inclusion Criteria:
- Surgery patients (toxicity and protein assimilation) : BMI > 40 kg/m² or > 35 kg/m² if combined with either obstructive sleep apnoea syndrome, high blood pressure not controllable with 3 different medications or type II diabetes, (3) exclusion of other underlying causes of obesity by an endocrinologist, (4) having tried to lose weight on a non-surgical way for at least 1 year without result and (5) a positive advice from a multidisciplinary team consisting of a surgeon, endocrinologist, psychologist and dietitian.
- Obese control group in weight loss program (toxicity) : obese but otherwise healthy patients on a weight loss diet (BMI > 30 kg/m²) in the context of the weight-loss program organised at the Obesity Clinic of University Hospital Leuven.
- Control group (protein assimilation) : normal weight (BMI 25-30 kg/m²) or overweight (BMI 25-30 kg/m²).
Exclusion Criteria:
- Intake of antibiotics 1 months before the start of the study. Pre-and probiotics, laxatives and anti-diarrhea drugs 2 weeks before the start of the study.
- Surgery patients and control group (toxicity) : Gastrointestinal disease or major abdominal surgery in the past (except from appendectomy and cholecystectomy).
- Surgery patients and control group (protein assimilation) : Lung, liver, kidney and gastrointestinal disease or major abdominal surgery in the past (except from appendectomy, cholecystectomy and bariatric surgery). Vegan, vegetarian, lactose-or gluten-free diet. Pregnant or lactating women and subjects who participated in the last year in a study with irradiation exposure.
Studieplan
Hvordan er studiet utformet?
Designdetaljer
Kohorter og intervensjoner
Gruppe / Kohort |
|---|
|
Roux-en-Y gastric bypass
Patients who were planned for surgery with Roux-en-Y gastric bypass and were operated
|
|
Sleeve Gastrectomy
Patients who were planned for surgery with Sleeve Gastrectomy and were operated
|
|
Control group
Obese patients involved in a weight loss program that focuses on diet and lifestyle changes
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Change from baseline in toxicity of faecal water up to 1 year after bariatric surgery
Tidsramme: Baseline and 2 weeks, 3 months, 6 months and 1 year after surgery
|
Faecal water toxicity : measured with a cell viability test.
Toxicity : expressed as the dilution of faecal water at which 50 percent of the cells survive.
|
Baseline and 2 weeks, 3 months, 6 months and 1 year after surgery
|
|
Degree of protein assimilation 6-24 months after bariatric surgery
Tidsramme: 6-24 months after surgery
|
Protein digestion, malabsorption and fermentation : assessed with stable isotope technology.
Digestion and malabsorption : expressed as percent of the administered isotope dose.
Fermentation : expressed as percent of maximal dose of the fermentation product that can be formed.
|
6-24 months after surgery
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Degree of fat malabsorption 6-24 months after bariatric surgery
Tidsramme: 6-24 months after surgery
|
Malabsorption of fat : calculated as ((fat intake- fat excretion)/fat intake)*100%, expressed as coefficient of fat absorption.
Excretion : measured with the Van de Kamer method.
|
6-24 months after surgery
|
Samarbeidspartnere og etterforskere
Sponsor
Etterforskere
- Hovedetterforsker: Kristin Verbeke, PhD, KU Leuven
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Primær fullføring (Faktiske)
Studiet fullført (Faktiske)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Andre studie-ID-numre
- s59836
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .